UBI — Universal Biosensors Balance Sheet
0.000.00%
Last trade - 00:00
- AU$41.73m
- AU$25.41m
- AU$6.63m
- 54
- 24
- 45
- 38
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 30.2 | 23.6 | 15.3 | 26 | 10.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.117 | 0.073 | 0.476 | 5.71 | 5.9 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 37.1 | 31.4 | 24.9 | 36.7 | 22 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.75 | 8.38 | 6.15 | 9.06 | 7.56 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 62.7 | 56.4 | 44.5 | 46.1 | 30 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.2 | 8.96 | 9.4 | 13.1 | 5.95 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 17.3 | 18.4 | 16.9 | 20.1 | 10.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 45.4 | 38 | 27.6 | 26.1 | 19.5 |
Total Liabilities & Shareholders' Equity | 62.7 | 56.4 | 44.5 | 46.1 | 30 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |